SALT LAKE CITY--(BUSINESS WIRE)--Recursion, a digital biology company industrializing drug discovery, today announced it has entered into a global licensing agreement with Takeda Pharmaceutical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback